This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Pregabalin in epilepsy

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Pregabalin is an antiepileptic medication that works by binding to alpha 2 delta subunit of the voltage-dependent calcium channels present in presynaptic neurons

  • its pharmacokinetic advantages include rapid and almost complete absorption, lack of protein binding, linear kinetics, absence of enzyme induction, and absence of interactions with other drugs
    • like gabapentin it works by binding to alpha 2 delta subunit of the P/Q-type voltage-sensitive Ca2+ channels (VSCC) which are present in presynaptic neurons
    • pregabalin is structurally related to both the neurotransmitter gamma- aminobutyric acid (GABA), and the older antiepileptic drug, gabapentin
    • the primary mechanism underlying the pharmacological action of pregabalin does not appear to involve the GABA system
      • in particular, pregabalin does not bind to GABA-A, GABA-B, or benzodiazepine receptors
        • pregabalin is neither metabolically converted to GABA or to a GABA agonist, nor does it have any effect on the uptake or degradation of GABA.
    • does not block calcium channels rather it modulates calcium channels
    • is rapidly and completely absorbed after oral dosing in the fasting state (bioavailability is >90%) (1)
      • absorption is not dose-dependent
      • is not protein-bound
      • maximal plasma concentrations are reached in 1 hour after single or multiple doses, and steady state is achieved within 24 to 48 hours after repeated administration
        • therefore, pregabalin can be taken with or without food

  • is approved in multiple countries worldwide as an add-on therapy for focal onset seizures in adult and paediatric populations (2)

  • a systematic review found pregabalin significantly more effective than placebo at producing a 50% or greater seizure reduction and seizure freedom with increasing effectiveness at 600 mg doses, although with tolerability issues (2)

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.